Civica, Inc. has selected Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for the company’s affordable insulins.   Civica announced previously that it intends to produce three insulin biosimilars—glargine, lispro and aspart. The products will be available both in vials and prefilled pens.   The company plans to sell the insulins at significantly lower prices than other insulins currently on the market.   “As a renowned injection device specialist with over 35 ye...